October 17, 2022: In OB/GYN, preterm delivery is one of our most difficult challenges. The causes are complicated and not well-understood. But the associated harms are clear and devastating. We all want an effective intervention that will reduce the number of babies delivered too early and lead to better maternal and fetal outcomes. Unfortunately, current data do not indicate that Makena is the solution we have been seeking.
Read More »On Medical Treatments & Products
Comments of National Center for Health Research Regarding the USPSTF Draft Evidence Review: Screening for Depression and Suicide in Adults
October 17, 2022: We are concerned screening for asymptomatic depression and suicide has more risks than benefits. Further research is needed to find methods that accurately identify at-risk patients.
Read More »Comments of National Center for Health Research The USPSTF Draft Evidence Review: Screening for Anxiety in Adults
October 17, 2022: We are concerned the USPSTF recommended anxiety screening does not have enough supporting evidence, and the resulting treatments come with serious risks.
Read More »NCHR Comment on CPSC Adoption of Mandatory Safety Standard for Infant Bouncer Seats
October 5, 2022: “The updated warning gives parents clear advice on how to avoid the possible hazards of using bouncer seats. In addition, making the safety standard mandatory will help ensure widespread compliance by manufacturers.”
Read More »National Center For Health Research Comments on Consumer Product Safety Standards for Frame Child Carriers
September 29, 2022 We are writing to express our strong support for the Consumer Product Safety Commission (CPSC) plan to adopt a mandatory standard for frame child carriers to improve safety by including more stringent requirements and test conditions. The National Center for Health Research (NCHR) is a nonprofit think tank that conducts, analyzes, and […]
Read More »